diltiazem has been researched along with adenosine-3',5'-cyclic phosphorothioate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Chang, TM; Chey, WY; Coy, DH; Erway, B | 1 |
| Barsegyan, A; McGaugh, JL; Roozendaal, B | 1 |
2 other study(ies) available for diltiazem and adenosine-3',5'-cyclic phosphorothioate
| Article | Year |
|---|---|
Modulation of secretin release by neuropeptides in secretin-producing cells.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bombesin; Cell Line; Cell Survival; Cells, Cultured; Cyclic AMP; Diltiazem; Egtazic Acid; Galanin; Gastrin-Releasing Peptide; Inositol 1,4,5-Trisphosphate; Intestinal Mucosa; Intestine, Small; Male; Neuropeptides; Neurotransmitter Agents; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Sprague-Dawley; Secretin; Tetradecanoylphorbol Acetate; Thionucleotides | 1998 |
Glucocorticoid effects on working memory impairment require l-type calcium channel activity within prefrontal cortex.
Topics: Animals; Calcium Channels, L-Type; Diltiazem; Glucocorticoids; Male; Memory Disorders; Memory, Short-Term; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 2023 |